Skov3 - OmicsDI

Show results for

Unknown (708)
Genomics (241)
Transcriptomics (140)
Proteomics (36)
Methylation profiling (3)
Metabolomics (2)
Other (1)

Organisms

Homo sapiens (160)
Andropogon gerardi (26)
Bacteria (26)
Botrytis cinerea (26)
Canis lupus familiaris (26)
Clostridium perfringens (26)
Cnidaria (26)
Cricetulus griseus (26)
Eukaryota (26)
Fasciola (26)
Hepatitis B virus (26)
Human betaherpesvirus 5 (26)
Japanese encephalitis virus group (26)
Mesocricetus auratus (26)
Miscanthus x giganteus (26)
Mycobacterium tuberculosis (26)
Orthoflavivirus (26)
Panicum virgatum (26)
Platyhelminthes (26)
Pseudomonas aeruginosa AES-1R (26)
Rickettsia (26)
Saccharomyces cerevisiae (26)
Schizosaccharomyces pombe (26)
Severe acute respiratory syndrome coronavirus 2 (26)
Shigella (26)
Sorghastrum nutans (26)
Streptococcus dysgalactiae subsp. equisimilis SK1249 (26)
Streptococcus pneumoniae (26)
Rattus norvegicus (2)
Mus musculus (1)

Organisms

Homo sapiens (186)
Mus musculus (2)
Rattus norvegicus (1)

Repository

ENA (224)
geo (107)
biostudies-arrayexpress (51)
pride (26)
iProX (5)
MassIVE (5)
ExpressionAtlas (3)
GNPS (1)
MetaboLights (1)

Tissue

Cell culture (12)
Epithelial cell (10)
Ovary (3)
Cell suspension culture (2)
Macrophage (2)
Adult stem cell (1)
HeLa cell (1)
Malignant cell (1)
Ovarian serous carcinoma cell (1)
Ovarian surface epithelial cell (1)
Ovary epithelium cell line (1)
Stem cell (1)

Disease

Malignant neoplasm of ovary (16)
Ovarian cancer (2)
Ovary epithelial cancer (1)

Technology Type

Mass Spectrometry (26)
Shotgun proteomics (21)
Affinity purification coupled with mass spectrometry proteomics (3)
Mass spectrometry assay (1)
Bottom-up proteomics (1)
Data-independent acquisition (1)
SRM/MRM (1)

Instrument Platform

Illumina NovaSeq 6000 (3)
NextSeq 500 (2)
TimsTOF fleX (2)
Q Exactive (2)
Agilent microarray scanner (1)
Illumina HiSeq 1500 (1)
Illumina HiSeq 4000 (1)
Autoflex II (1)
MaXis II (1)
Q Exactive HF (1)
TripleTOF 5600 (1)
Liquid Chromatography MS - alternating - reverse phase (1)
Liquid Chromatography MS - positive - reverse phase (1)

Publication Date

2024 (24)
2022 (19)
2025 (13)
2015 (13)
2016 (12)
2017 (12)
2021 (11)
2018 (11)
2014 (11)
2013 (11)
2012 (11)
2026 (10)
2011 (9)
2019 (8)
2020 (7)
2023 (6)
2009 (5)
2010 (2)
2008 (2)
2007 (1)
2005 (1)

Metabolite Name

Sphingosine-1-phosphate (1)
C17 Sphinganine-1-phosphate (1)
C17 Sphinganine (1)
Sphingosine (1)

First Public Date

2024 (35)
2014 (28)
2026 (24)
2025 (22)
2022 (21)
2021 (15)
2020 (14)
2023 (13)
2018 (13)
2017 (11)
2015 (11)
2019 (9)
2016 (8)

Study type

Transcription profiling by array (38)
ChIP-seq (3)
RNA-seq of coding RNA (3)
Cell line - High-throughput sequencing (2)
RNA-seq of total RNA (2)
Unknown experiment type (1)
Cell line - One-color microarray (1)
Comparative genomic hybridization by array (1)

Release Date

2022 (88)
2021 (83)
2020 (72)
2024 (67)
2016 (55)
2025 (54)
2017 (50)
2023 (47)
2019 (47)
2014 (38)
2013 (35)
2018 (32)
2015 (32)
2012 (16)
2011 (11)
2010 (9)
2009 (8)
2026 (8)
2008 (4)
2007 (2)
2002 (1)

Lab affiliation

Systems Biology Laboratory, Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency (2)
Université de Lille, Sciences et Technologies - INSERM U1192 - Laboratoire PRISM, France (2)
Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine (1)
Assistant Professor, School of Biomedical Sciences, Faculty of Medicine, The University of Hong Kong, HK SAR (1)
Associate Professor, Head Cancer Proteomics Group, University of Queensland Diamantina Institute, Woolloongabba, QLD, 4102 (1)
Biomolecular Mass Spectrometry and Proteomics, Bijvoet Center for Biomolecular Research and Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands (1)
Core Facilities, Istituto Giannina Gaslini, Genoa, Italy (1)
Department of Analytical Biochemistry, Groningen Research Institute of Pharmacy, University of Groningen, 9713 AV Groningen, The Netherlands. (1)
Department of obstetrics and gynecology. Second affiliated hospital of Harbin Medical University. Harbin, Heilongjiang, China. (1)
Drug Discovery Moffitt Cancer Center Tampa, FL, USA (1)
Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency (1)
Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency, Russia (1)
Ist. G. Gaslini (1)
Laboratory of Experimental Cancer Research, Department of Human Structure and Repair, Ghent (1)
Laboratory of Proteomics, Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry of the Russian Academy of Sciences (1)
Moffitt Cancer Center Tampa, FL, USA (1)
Nanjing Medical Key Laboratory of Female Fertility Preservation and Restoration, Nanjing 210004, China (1)
Princess Margaret Cancer Center, Toronto, ON, Canada. (1)
Professor, PhD Department of Biochemistry and Molecular Biology Southern Denmark University (1)
Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry of the Russian Academy of Sciences (1)
Systems Biology Laboratory, Lopukhin Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency (1)
The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital,Suzhou 215002, China (1)
The University of Texas MD Anderson Cancer Center (1)
Zhejiang University (1)

Previous page
1 / 114
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 114
Next page

Sort by:

Relevance

Page size

Comparative glycomics study on the surface of SKOV3 versus IOSE80 cell lines

Both SKOV3 and IOSE80 cells were cultured and extracted the proteins. With sequential digestion by trypsin, enriched by Zwitterionic Hydrophilic Interaction chromatography (ZIC-HILIC), the intact N-glycopeptides were then isotopic diethyl labelled and analyzed using C18-RPLC-MS/MS (HCD).

ORGANISM(S): Homo sapiens (Human)

2023-03-10 | PXD030927 | Pride

Skov3 iose80

RNAseq of SKOV3(AA) and SKOV3(CC)

PRJNA753808 | ENA

EZH2 and H3K27ac ChIPseq of SKOV3(AA) and SKOV3(CC)

PRJNA771867 | ENA

H3K27ac, H3K4me3, H3K27me3 and H3K9me3 ChIPseq of SKOV3(AA) and SKOV3(CC)

PRJNA755883 | ENA

Next Generation Sequencing of Transcriptomes in SKOV3 and rhCCL20-treated SKOV3 cells

PRJNA679482 | ENA

Expression data from SKOV3 KO1#_Vector and SKOV3 KO1#_MED12 rescued cells

PRJNA449385 | ENA

Differential gene expression profiles between SKOV3.ip1-S116A cells (Ser116 of PEA-15 substituted with alanine) and SKOV3.ip1-S116D cells (Ser116 of PEA-15 substituted with aspartic acid).

To dissect the molecular mechanisms of PEA-15-mediated paclitaxel sensitization in ovarian cancer cells, we performed cDNA microarray analysis using SKOV3.ip1-S116A cells (Ser116 of PEA-15 substituted with alanine) and SKOV3.ip1-S116D cells (Ser116 of PEA-15 substituted with aspartic acid). cDNA mic...

ORGANISM(S): Homo sapiens

2012-05-11 | E-GEOD-37934 | biostudies-arrayexpress

Sequencing in transcriptomes in Ovarian cancer cell line SKOV3 and bevacizumab-treated SKOV3

PRJNA694568 | ENA

LncRNA/mRNA expression in SKOV3/SKOV3_DDP/IOSE80

PRJNA413797 | ENA

Gene expression change in Skov3 after EZH2 knockdown

To identify genes whose expression was suppressed by EZH2, we performed gene expression microarray analysis in control and EZH2 knockdown human SKOV3 EOC cells. Two individual short hairpin RNAs to the human EZH2 gene (shEZH2) were used to limit potential off-target effects. Two individual short hai...

ORGANISM(S): Homo sapiens

2011-12-12 | E-GEOD-31433 | biostudies-arrayexpress

Previous page
1 / 114
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 114
Next page

Sort by:

Relevance

Page size

1131 Results

Show results for

Organisms

Organisms

Repository

Tissue

Disease

Technology Type

Instrument Platform

Publication Date

Metabolite Name

First Public Date

Study type

Release Date

Lab affiliation

Tags

OmicsDI is part of the ELIXIR infrastructure

Tweets